LG Display Co. Ltd.

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...

Related tickers: RDHL, MRAI, MPX, AAL, IMMX, NOK, NEP, ALTI, CCTG, ORI, RR, AMSC, CISS, POL, VIRT, COLB, VSME, TAL, CNXC, EPIX, URI, EVA, RVSN, WRB, AKTS, ALK, XRX, INSG, ATI, TSLA, CMND, CRS, VERA, PCSA, CYN, ALPN, HUT, HUM, PHUN, RXT, HXL, PROP, ONCO, AFIB, HZO, CRGE, LVTX, IBM, ADT, BMEA, LPL.

Shares of International Business Machines Corporation (NYSE: IBM) shares rose sharply in today’s pre-market trading as the company reported reported stronger-than-expected results for its fourth quarter. IBM said fourth-quarter revenue increased 4% year-over-year to $17.38 billion, which beat the consensus estimate of $17.3 billion, according to Benzinga Pro. The company noted that the continued adoption of hybrid cloud and AI offerings drove its strong revenue results. IBM reported quarterly adjusted earnings of $3.87 per share versus estimates of $3.78 per share. IBM shares jumped 7.4% to $186.82 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers C3is Inc. (NASDAQ: CISS) gained 48.6% to $0.1970 in pre-market trading. Aegis Capital Corp. acted as sole bookrunner on an upsized $7.0 million underwritten public offering for C3is. Charge Enterprises, Inc. (NASDAQ: CRGE) gained 42% to $0.2090 in pre-market trading following a 6% decline on Wednesday. Acutus Medical, Inc. (NASDAQ: AFIB) shares jumped 39% to $0.3085 in pre-market trading. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods ...

Related tickers: EFSH, AFIB, AMSC, CCCS, COLB, CISS, HXL, VSME, IBM, GVH, LPL, NOK, TSLA, PHUN, ONCO, CRGE, SPCB, AGE, CTM, AKTS.